Condensed Balance Sheets - USD ($)		Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash		$ 257,621	$ 30,511
Prepaid expenses		234,359
Total Current Assets		491,980	30,511
Deferred offering costs			168,973
Investments held in Trust Account – US Treasury Securities Money Market Fund		139,406,212
TOTAL ASSETS		139,898,192	199,484
Current liabilities
Accrued offering costs			25,760
Accrued expenses		20,025
Advances from related party			30,000
Promissory note — related party			125,000
Total Current Liabilities		20,025	180,760
Warrant liability		3,693,600
Deferred underwriting fee payable		5,190,000
Total Liabilities		8,903,625	180,760
Commitments and Contingencies
Ordinary shares subject to possible redemption 12,472,363 as of June 30, 2021 and no shares as of December 31, 2020 at redemption value of $10.10		125,994,557
Shareholders’ Equity
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 4,777,637 and 3,450,000 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively	[1]	478	345
Additional paid-in capital		3,910,704	24,655
Retained earnings (accumulated deficit)		1,088,828	(6,276)
Total Shareholders’ Equity		5,000,010	18,724
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY		$ 139,898,192	$ 199,484

[1] At December 31, 2020, includes an aggregate of up to 450,000 ordinary shares that are subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised (see Note 6). On January 6, 2021, the Company effected a share capitalization of 0.2 shares for each share outstanding, resulting in 3,450,000 ordinary shares issued and outstanding (see Note 6). All share and per share amounts have been retroactively restated to reflect the share capitalization.  As a result of the underwriters’ full exercise of their overallotment option on January 11, 2021, no shares were forfeited.